8-K filed June 2, 2026, 4:23 PM ET ticker ARDT CIK 0001756655

leadership confidence high sentiment neutral materiality 0.70

Ardent Health appoints Dave Caspers as CEO, reaffirms FY 2026 EBITDA guidance

Ardent Health, Inc.

Dave Caspers appointed President and CEO, effective June 2, 2026, succeeding Marty Bonick.
Caspers receives $900k base salary, 105% target bonus, RSUs ($1.05M) and PRSUs ($1.95M target).
Company reaffirms FY 2026 Adjusted EBITDA guidance of $485M-$535M despite Q2 volume softness.
CFO says Q2 volume softness observed; IMPACT program accelerated to improve margins.
Caspers also appointed to Board of Directors.

item 5.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-253567
form_type: 8-K
ticker: ARDT
cik: 0001756655
company_name: Ardent Health, Inc.
filed_at: 2026-06-02T20:23:36+00:00
discovered_at: 2026-06-02T20:26:00.212160+00:00
generated_at: 2026-06-02T20:26:24.729991+00:00
sec_items: ["5.02", "7.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-253567
json_url: https://secwatch.observer/filing/0001193125-26-253567.json
markdown_url: https://secwatch.observer/filing/0001193125-26-253567.md
text_url: https://secwatch.observer/filing/0001193125-26-253567.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1756655/000119312526253567/0001193125-26-253567-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1756655/000119312526253567/d854796d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Martin J. Bonick

Chief Executive Officer

ARDT · Ardent Health, Inc.

Effective: 2026-06-02
Successor: Dave Caspers
Filed: June 2, 2026, 4:23 PM ET

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Appointed

Dave Caspers

President and Chief Executive Officer

ARDT · Ardent Health, Inc.

Effective: 2026-06-02
Filed: June 2, 2026, 4:23 PM ET

On June 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Ardent Health, Inc. (the “Company”) appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board.

Source-grounded claims

0c17ef1aad

Martin J. Bonick departed as Chief Executive Officer at Ardent Health, Inc..

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

9edc684027

Dave Caspers was appointed as President and Chief Executive Officer at Ardent Health, Inc..

On June 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Ardent Health, Inc. (the “Company”) appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

BTMD

Biote CEO Christensen resigns; CFO Peterson named Interim CEO; Marc Beer Executive Chairman; FY2026 guidance reaffirmed

biote Corp. June 2, 2026, 5:17 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

On June 1, 2026, the Board appointed Marc Beer as Executive Chairman of the Board, effective June 8, 2026.

Filing page SEC filing

CYCU

Cycurion appoints Ana Garcia as CFO; Alvin McCoy III transitions to strategic advisor

Cycurion, Inc. June 2, 2026, 4:43 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.

Filing page SEC filing

ALH

COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR

Alliance Laundry Holdings Inc. June 2, 2026, 9:16 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026

Filing page SEC filing

CRVL

CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026

CORVEL CORP June 1, 2026, 5:05 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.

Filing page SEC filing

WST

West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair

WEST PHARMACEUTICAL SERVICES INC June 1, 2026, 4:32 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.

Filing page SEC filing

LPX

LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026

LOUISIANA-PACIFIC CORP June 1, 2026, 4:31 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.

Filing page SEC filing

VRRM

Verra Mobility CEO David Roberts steps down amid cost realignment; interim CEO Keyser appointed

VERRA MOBILITY Corp June 1, 2026, 4:29 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

On June 1, 2026, Verra Mobility Corporation (the “Company”) announced that the Board of Directors of the Company (the “Board”) approved the appointment of Jonathan Keyser as the Interim President and Chief Executive Officer of the Company, effective May 31, 2026.

Filing page SEC filing

PENG

Penguin Solutions CFO Nate Olmstead to step down; Aaron Johnson named interim CFO; reaffirms FY2026 guidance at high end

Penguin Solutions, Inc. June 1, 2026, 4:17 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Comparable filing

On May 31, 2026, the board of directors of the Company appointed Aaron Johnson, the Company’s Vice President, Finance and Accounting, as interim CFO and as the Company’s principal financial and accounting officer, succeeding Mr. Olmstead in these positions effective as of July 9, 2026, on an interim basis until the Company appoints a successor.

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-26-253567

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.